RxNorm Concept ID 896186

fluticasone propionate/salmeterol 250/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters

Semantic Concepts

RxNorm semantic concepts for the RxCUI 896186 unique identifier include: fluticasone propionate/salmeterol 250/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters (6372101) and 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler (12343780).

RxNorm Atom ID: 6372101 - Prescribable Name

fluticasone propionate/salmeterol 250/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters

Field NameField ValueField Description
RXCUI896186RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI6372101Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionfluticasone propionate/salmeterol 250/50 MCG/INHAL Dry Powder Inhaler, 14 BlistersDescription of concept identifier
Term Type (TTY)PSNTerm type in source with name and description
Term Type NamePrescribable NameName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.Description of term type in source
CODE896186"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 12343780 - Semantic Clinical Drug

14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler

Field NameField ValueField Description
RXCUI896186RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI12343780Unique identifier for the atom (RxNorm Atom ID)
Concept Description14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder InhalerDescription of concept identifier
Term Type (TTY)SCDTerm type in source with name and description
Term Type NameSemantic Clinical DrugName of term type in source
Term Type DescriptionIngredient + Strength + Dose FormDescription of term type in source
CODE896186"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 12343780 Attributes

PropertyValueExplanation
RXN AI{331524} 72616RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI{896024} 50121RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{331524} 36117RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM{896024} 41126RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH0.25 MG/ACTUAT / 0.05 MG/ACTUATAvailable drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM{331524} AMSource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM{896024} AISource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUGUSDrug available for use in Humans
RXN QUANTITY14 ACTUATNormal Form quantity factor
RXTERM FORMDPIThe RxTerm dose form name for this drug

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Information for Patients

Fluticasone and Salmeterol Oral Inhalation

The combination of fluticasone and salmeterol (Advair Diskus, Advair HFA, AirDuo Respiclick) is used to treat difficulty breathing, wheezing, shortness of breath, coughing, and chest tightness caused by asthma. The combination of fluticasone and salmeterol (Advair Diskus) is also used to prevent and treat wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). The combination of fluticasone and salmeterol (Advair Diskus) is used in adults and children 4 years of age and older. The combination of fluticasone and salmeterol (Advair HFA, AirDuo Respiclick) is used in children 12 years of age and older. Fluticasone is in a class of medications called steroids. It works by reducing swelling in the airways. Salmeterol is in a class of medications called long-acting beta-agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Read More]

* Please review the disclaimer below.